Psychiatry & Neurology, Addiction Medicine · Stilwell, OK
NPI
1639530769
Since 2016
Specialty
Psychiatry & Neurology, Addiction Medicine
Code 2084A0401X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1401 W Locust St
Stilwell, OK, 74960
Phone (918) 696-3101
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
171 services
Medicare patients, 2024
92
Average age 56
Drug cost, 2024
$1.4M
3,114 prescriptions
Company payments, 2025
$1,743
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Peyok was code 99214 (office e&m - established), 64 times for 36 patients. In total David Peyok billed 171 services in 15 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 64 | 36 | $71.02 | $4,546 |
| 96372 Injection Administration | Office | 27 | 12 | $5.40 | $146 |
| 99231 Hospital E&M - Subsequent | Facility | 20 | 16 | $36.81 | $736 |
| 99283 Emergency Department E&M | Facility | 13 | 13 | $53.19 | $692 |
By year: 2022 $19K for 271 services; 2023 $14K for 227 services; 2024 $10K for 171 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Peyok prescribed most often to Medicare patients was Lamotrigine, with 217 prescriptions and refills. In total David Peyok wrote 3,114 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 217 | 253 | 40 | $2,038 |
| Mirtazapine Generic | 166 | 174 | 27 | $3,437 |
| Olanzapine Generic | 146 | 155 | 23 | $5,343 |
| Perseris Risperidone | 129 | 129 | 20 | $365K |
| Quetiapine Fumarate Generic | 129 | 146 | 19 | $6,260 |
| Gabapentin Generic | 105 | 127 | 17 | $2,939 |
| Trazodone Hcl Generic | 99 | 122 | 21 | $1,662 |
| Diazepam Generic | 96 | 96 | 15 | $944 |
| Duloxetine Hcl Generic | 79 | 92 | 11 | $3,079 |
| Invega Sustenna Paliperidone Palmitate | 75 | 75 | 12 | $259K |
| Oxcarbazepine Generic | 68 | 74 | Under 11 | $3,457 |
| Benztropine Mesylate Generic | 66 | 68 | Under 11 | $965 |
| Fanapt Iloperidone | 65 | 65 | Under 11 | $130K |
| Risperidone Generic | 64 | 75 | 15 | $1,779 |
| Caplyta Lumateperone Tosylate | 61 | 61 | 12 | $103K |
Brand drugs: 506 claims; generic drugs: 2,608 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Peyok $1,743 ($1,743 in general payments such as food, travel and fees) from 9 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $706.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 47 | $706 |
| Neurocrine BioSciences, Inc. NBIX | 25 | $264 |
| Vanda Pharmaceuticals Inc. VNDA | 21 | $220 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $195 |
| Alkermes, Inc. ALKS | 4 | $97.72 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $88.03 |
| Abbvie Inc. ABBV | 4 | $76.43 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $64.38 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $32.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.